Meclizine Hydrochloride
Product Images NDC 67296-1432

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 67296-1432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12.5mg (12 5mg 100ct)

FDA Label Image

25mg-100ct-chew (25mg 100ct Chew)

25mg-100ct-chew (25mg 100ct Chew)
This is a description of Rising brand Meclizine Hydrochloride Chewable Tablets. Each container has 100 tablets with 25 mg meclizine dihydrochloride equivalent to 21.07 mg of meclizine free base in each chewable tablet. Patients must chew or crush the tablet before swallowing to take the usual dosage. It is recommended to see the prescribing information for more guidance. Usual dosage is between 25mg to 100mg per day depending on clinical response. The medication should be stored between 20°C and 25°C and must be kept away from children in a tight, light-resistant container. Distributed by Fising Pramaceuicas, Inc based in Saddlebrook, NJ and made in India.*
FDA Label Image

25mg-100ct (25mg 100ct)

25mg-100ct (25mg 100ct)
Rising® NDC 16571-661-01 Meclizine Hydrochloride Tablets, USP is a medication that is available in 100 tablets of 25 mg meclizine dihydrochloride equivalent 102107 mg of meclizine free base. The usual dosage is explained in the accompanying prescribing information. It is used in treating vertigo, and the dosages depend on the clinical response. It should be dispensed in tight, light-resistant containers and kept out of reach of children. It should be stored between 20° to 25°C (68" to T7°F) as per USP Controlled Room Temperature Regulations. It is distributed by Rising Pharmaceuticals, Inc. in Saddle Brook, NJ 07663, and made in India. The code mentioned is TS/DAUGS/22/2008. The product was issued in 08/2019.*
FDA Label Image

50mg-100ct (50mg 100ct)

50mg-100ct (50mg 100ct)
Rising® NDC 16571-662-01 is a medication consisting of 100 tablets of Meclizine Hydrochloride. Each tablet contains 50 mg of meclizine dihydrochloride equivalent to 42.14 mg of meclizine free base. The usual dosage can be found in the accompanying prescribing information. The medication is used to treat vertigo, and the dosage ranges from 25 mg to 100 mg in divided doses daily, depending on clinical response. It should be kept in tight, light-resistant containers out of reach of children and stored at 20° to 25°C (68° to 77°F). The medication is distributed by Rising Pharmaceuticals, Inc., Saddle Brook, NJ 07663, and is made in India. The code for the medication is TS/DAUGS/22/2008, and the medication was issued in August 2019.*
FDA Label Image

30 Count (67296 1432)

30 Count (67296 1432)
This is a description of a medication container, specifically for Meclizine HCL, which comes in a bottle containing 30 tablets. The NDC code for this product is 67296-1432-3, and the lot number is 20015AX1, with an expiration date of 10/22. The adult dosage is listed on the package, and the medication should be stored at a controlled room temperature of 20-25C (68-77 F). The container was distributed by Redpharm Drug in Eden Prairie, MN.*
FDA Label Image

Struct-1 (Struct 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.